Seoul, South Korea

Hyong Bai Kim

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyong Bai Kim. Retrieved from https://idiyas.com/inventor/hyong-bai-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyong Bai Kim: Innovator in Gene-Targeted Deletion Methods

Introduction

Hyong Bai Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for gene-targeted deletions. His innovative work has implications for drug screening and genetic research.

Latest Patents

Hyong Bai Kim holds 1 patent. His patent describes a method that involves transforming with a deletion cassette, constructed by four-round serial PCR, block PCR, or total gene synthesis. This method contains a homologous recombination site and is designed for preparing gene-targeted heterozygous deletions. Additionally, the patent includes gene-targeted heterozygous deletion mutants prepared by this method, along with a library of these mutants. This library is particularly useful for constructing methods and kits for screening a drug's modes of action.

Career Highlights

Hyong Bai Kim is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on cutting-edge research in genetic engineering and biotechnology.

Collaborations

Some of his notable coworkers include Kwang Lae Hoe and Dong Uk Kim. Their collaborative efforts contribute to the advancement of research in their field.

Conclusion

Hyong Bai Kim's innovative methods in gene-targeted deletions represent a significant advancement in biotechnology. His contributions are paving the way for new approaches in drug screening and genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…